麦角隐碱作为泌乳抑制剂

Gynecologic investigation Pub Date : 1974-01-01 DOI:10.1159/000301647

M D Falzon, R Galea, A P Cmailleri

{"title":"麦角隐碱作为泌乳抑制剂","authors":"M D Falzon, R Galea, A P Cmailleri","doi":"10.1159/000301647","DOIUrl":null,"url":null,"abstract":"A double-blind trial was performed on 40 parturient women to compare the efficacy of an ergocryptine (CB 154) as a lactation inhibitor in comparision with chlorotrianisine (TACE). The two drugs were about equally effective. The drug CB 154 is unlikely to be associated with puerperal thrombo-embolism, it does not seem to be followed by rebound lactation, and it may prove particularly effective in women with a previous history of puerperal mastitis or breast engorgement.","PeriodicalId":75889,"journal":{"name":"Gynecologic investigation","volume":"5 3","pages":"133-8"},"PeriodicalIF":0.0000,"publicationDate":"1974-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000301647","citationCount":"3","resultStr":"{\"title\":\"An ergocryptine as a lactation inhibitor.\",\"authors\":\"M D Falzon, R Galea, A P Cmailleri\",\"doi\":\"10.1159/000301647\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A double-blind trial was performed on 40 parturient women to compare the efficacy of an ergocryptine (CB 154) as a lactation inhibitor in comparision with chlorotrianisine (TACE). The two drugs were about equally effective. The drug CB 154 is unlikely to be associated with puerperal thrombo-embolism, it does not seem to be followed by rebound lactation, and it may prove particularly effective in women with a previous history of puerperal mastitis or breast engorgement.\",\"PeriodicalId\":75889,\"journal\":{\"name\":\"Gynecologic investigation\",\"volume\":\"5 3\",\"pages\":\"133-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1974-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000301647\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000301647\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000301647","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 3

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

An ergocryptine as a lactation inhibitor.

A double-blind trial was performed on 40 parturient women to compare the efficacy of an ergocryptine (CB 154) as a lactation inhibitor in comparision with chlorotrianisine (TACE). The two drugs were about equally effective. The drug CB 154 is unlikely to be associated with puerperal thrombo-embolism, it does not seem to be followed by rebound lactation, and it may prove particularly effective in women with a previous history of puerperal mastitis or breast engorgement.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Gynecologic investigation

自引率

0.00%

发文量